Company Filing History:
Years Active: 2012
Title: Atsushi Ogiwara: Innovator in Postoperative Prognosis Prediction
Introduction
Atsushi Ogiwara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in predicting postoperative outcomes for lung adenocarcinoma patients. His innovative approach combines biological analysis with clinical prognosis, showcasing the intersection of technology and healthcare.
Latest Patents
Atsushi Ogiwara holds a patent for a method titled "Method for prediction of postoperative prognosis and diagnosis kit." This invention relates to a technique for predicting the postoperative prognosis of lung adenocarcinoma patients with high sensitivity and specificity. The method involves determining the expression levels of myosin IIA and/or vimentin in biological samples collected from patients. Based on these expression levels, the prognosis can be accurately predicted or determined.
Career Highlights
Ogiwara is associated with Medical Proteoscope Co., Ltd., where he applies his expertise in medical technology and innovation. His work focuses on enhancing diagnostic methods that can lead to better patient outcomes. With a patent portfolio that includes one significant patent, he continues to push the boundaries of medical research and application.
Collaborations
Atsushi Ogiwara collaborates with talented individuals in his field, including Yousuke Fukui and Shingo Akimoto. These partnerships foster a creative environment that encourages the development of groundbreaking medical technologies.
Conclusion
Atsushi Ogiwara's contributions to the field of medical diagnostics exemplify the importance of innovation in healthcare. His patented method for predicting postoperative prognosis represents a significant advancement in the treatment of lung adenocarcinoma. Through his work, Ogiwara continues to impact patient care positively.